RE:RE:RE:Back again
Honestly i lost hope on this one in december but all of a sudden news drop of fda came as a surprise. I think this team has a potential and ryplazim is a not a big deal i guess. PBI 4050 is what i am more interested in. I am sure things will look very bright if theh restart PBI and Ryplazim approval. I guess this is a multibagger from here. Having said that, this price decrease is indeed a matter of worry because i remeber seing same action back in Jan 2017 when we were about to get approval and just before we saw price sinking.